ChemMedChem

Cover image for Vol. 10 Issue 4

Editor-in-Chief: Natalia Ortúzar

Impact Factor: 3.046

ISI Journal Citation Reports © Ranking: 2013: 18/58 (Chemistry Medicinal); 75/256 (Pharmacology & Pharmacy)

Online ISSN: 1860-7187

Associated Title(s): Angewandte Chemie International Edition, Chemistry - A European Journal, Chemistry – An Asian Journal, ChemBioChem, Medicinal Research Reviews, Molecular Informatics

Recently Published Issues

See all

Latest News

Browse more news

Facebook

Follow ChemMedChem on Twitter

March 24, 2015

2015 FMC in Marburg

2015 FMC in MarburgThe 2015 Frontiers in Medicinal Chemistry conference (www.gdch.de/medchem2015), organized by the German Chemical and Pharmaceutical Societies, together with the Swiss Chemical Society, was held last week at the Philipps University, Marburg (Germany). Read more...

Your Comment...

[Browse more news]

Recently Published Articles

  1. New Approaches in the Design and Development of Cannabinoid Receptor Ligands: Multifunctional and Bivalent Compounds

    Martin Nimczick and Prof. Dr. Michael Decker

    Article first published online: 27 MAR 2015 | DOI: 10.1002/cmdc.201500041

    Thumbnail image of graphical abstract

    Bivalent and multifunctional ligands acting at diverse biological targets were recently designed, synthesized and characterized for both cannabinoid receptor subtypes (CBRs). Due to their altered receptor binding and pharmacological profiles, they represent interesting tools to explore CBR functions and their interactions with other physiological systems. Moreover, this approach may bear therapeutic advantages in the therapy of CBR-related disorders, especially multifactorial diseases.

  2. Indanones As High-Potency Reversible Inhibitors of Monoamine Oxidase

    Samantha Mostert, Prof. Anél Petzer and Prof. Jacobus P. Petzer

    Article first published online: 27 MAR 2015 | DOI: 10.1002/cmdc.201500059

    Thumbnail image of graphical abstract

    Location, location, location: C6-substituted indanones 3 are highly potent and selective MAO-B inhibitors, with IC50 values ranging from 0.001–0.030 μM. C5-substituted indanone (2) and indane (4) derivatives are comparatively weaker MAO-B inhibitors. C6-substituted indanones are thus promising leads for the design of therapies for Parkinson’s disease.

  3. Indolo[3,2-c]quinoline G-Quadruplex Stabilizers: a Structural Analysis of Binding to the Human Telomeric G-Quadruplex

    Dr. João Lavrado, Dr. Stephan A. Ohnmacht, Dr. Isabel Correia, Clara Leitão, Sílvia Pisco, Dr. Mekala Gunaratnam, Prof. Rui Moreira, Prof. Stephen Neidle, Dr. Daniel J. V. A. dos Santos and Dr. Alexandra Paulo

    Article first published online: 26 MAR 2015 | DOI: 10.1002/cmdc.201500067

    Thumbnail image of graphical abstract

    A much higher IQ: We report indolo[3,2-c]quinoline (IQc) derivatives with two weak basic side chains as potent and selective human telomeric (HT) G-quadruplex (G4) stabilizers. Biophysical data show that stabilization involves the binding of two ligands which induces a conformational rearrangement of the HT G4 structure. Moreover, selected derivatives showed selective antiproliferative activity toward human malignant cell lines.

  4. Investigation of Structure–Activity Relationships of Synthetic Anti-Gonadotropin Releasing Hormone Vaccine Candidates

    Chenghung Chang, Dr. Pegah Varamini, Ashwini Kumar Giddam, Dr. Friederike M. Mansfeld, Prof. Dr. Michael J. D'Occhio and Prof. Dr. Istvan Toth

    Article first published online: 25 MAR 2015 | DOI: 10.1002/cmdc.201500036

    Thumbnail image of graphical abstract

    Gonadotropin-releasing hormone (GnRH) vaccine candidates were found to produce effective anti-GnRH-specific antibodies, resulting in significant inhibition of folliculogenesis in mouse ovaries. The compounds were efficiently taken up by antigen-presenting cells with significant immunogenicity without the need for an external adjuvant.

  5. Platinum(II) as Bifunctional Linker in Antibody–Drug Conjugate Formation: Coupling of a 4-Nitrobenzo-2-oxa-1,3-diazole Fluorophore to Trastuzumab as a Model

    Dr. Dennis C. J. Waalboer, Joey A. Muns, Dr. Niels J. Sijbrandi, Dr. Richard B. M. Schasfoort, Dr. Rob Haselberg, Prof. Dr. Govert W. Somsen, Dr. Hendrik-Jan Houthoff and Prof. Dr. Guus A. M. S. van Dongen

    Article first published online: 25 MAR 2015 | DOI: 10.1002/cmdc.201402496

    Thumbnail image of graphical abstract

    The missing link: [Pt(en)Cl2] was successfully used as a bifunctional linker in the conjugation of a variety of functionalized 4-nitrobenzo-2-oxa-1,3-diazole fluorophores to the model monoclonal antibody trastuzumab. The effect of ligand type, salt, and excipients on conjugation efficiency was explored. Conjugation was shown not to change the affinity of trastuzumab for its cognate antigen, Her2.

SEARCH

SEARCH BY CITATION